Inside Tract - A Picture of Hepatitis C Virus on the Run
A Picture of Hepatitis C Virus on the Run
Date: July 5, 2013
We’ve pulled the best bits from a bar graph that infectious disease expert Mark Sulkowski presented at last November’s annual meetings of the American Association for the Study of Liver Diseases. In the phase II trial Sulkowski led, the two newest—and gentler—direct-acting antiviral drugs, sofusbuvir and declatasvir, taken together, “disappeared” measureable virus from patients—across the usual subtypes, whether on a half-year or three month schedule.